法官称辉瑞未警告药品存在风险

　　A Pfizer Inc. unit failed to properly warn a New Jersey woman about the cancer risk of its hormone- replacement drug Provera and should pay $1.5 million in damages， jurors said in the first trial over the menopause treatment.

　　辉瑞旗下一家公司生产的荷尔蒙替代药品Provera存在引发癌症风险，而该公司又未能向服用者发出警告，故此一名新泽西妇女将其告上法庭。而法院一审裁定，辉瑞公司应该支付该女子150万美元作为赔偿。